Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1992 Feb;76(2):79–83. doi: 10.1136/bjo.76.2.79

Biological activities of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes.

M Boulton 1, P Moriarty 1, Z J Gregor 1
PMCID: PMC504166  PMID: 1371227

Abstract

This study compared the effects of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes on the proliferation and migration of retinal microvascular cells in vitro. Intraocular fluids were obtained from eyes undergoing repair of retinal detachment, due either to proliferative diabetic retinopathy or rhegmatogenous retinal detachment associated with a degree of proliferative vitreoretinopathy. The results demonstrated that the intraocular stimulatory activity for the proliferation of retinal microvascular endothelial cells varied between the different ocular compartments. The mitogenic and migrational activity in vitreous gel was greater than that of either the subretinal or retrohyaloid fluids of the same eye, and the activity of subretinal fluid was intermediate between that of the vitreous gel and the retrohyaloid fluid. There was no significant difference between the activities of the samples from diabetic and non-diabetic eyes.

Full text

PDF
79

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baird A., Culler F., Jones K. L., Guillemin R. Angiogenic factor in human ocular fluid. Lancet. 1985 Sep 7;2(8454):563–563. doi: 10.1016/s0140-6736(85)90512-4. [DOI] [PubMed] [Google Scholar]
  2. Baird A., Walicke P. A. Fibroblast growth factors. Br Med Bull. 1989 Apr;45(2):438–452. doi: 10.1093/oxfordjournals.bmb.a072333. [DOI] [PubMed] [Google Scholar]
  3. Boulton M. E., McLeod D., Garner A. Vasoproliferative retinopathies: clinical, morphogenetic and modulatory aspects. Eye (Lond) 1988;2 (Suppl):S124–S139. doi: 10.1038/eye.1988.139. [DOI] [PubMed] [Google Scholar]
  4. Campochiaro P. A., Jerdan J. A., Glaser B. M., Cardin A., Michels R. G. Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol. 1985 Sep;103(9):1403–1405. doi: 10.1001/archopht.1985.01050090155053. [DOI] [PubMed] [Google Scholar]
  5. Glaser B. M. Extracellular modulating factors and the control of intraocular neovascularization. An overview. Arch Ophthalmol. 1988 May;106(5):603–607. doi: 10.1001/archopht.1988.01060130657020. [DOI] [PubMed] [Google Scholar]
  6. Grant M., Russell B., Fitzgerald C., Merimee T. J. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization. Diabetes. 1986 Apr;35(4):416–420. doi: 10.2337/diab.35.4.416. [DOI] [PubMed] [Google Scholar]
  7. Lutty G. A., Chandler C., Bennett A., Fait C., Patz A. Presence of endothelial cell growth factor activity in normal and diabetic eyes. Curr Eye Res. 1986 Jan;5(1):9–17. doi: 10.3109/02713688608995160. [DOI] [PubMed] [Google Scholar]
  8. Singh A., Boulton M., Lane C., Forrester J., Gaal J., McLeod D. Inhibition of microvascular endothelial cell proliferation by vitreous following retinal scatter photocoagulation. Br J Ophthalmol. 1990 Jun;74(6):328–332. doi: 10.1136/bjo.74.6.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Taylor C. M., Kissun R. D., Schor A. M., McLeod D., Garner A., Weiss J. B. Endothelial cell-stimulating angiogenesis factor in vitreous from extraretinal neovascularizations. Invest Ophthalmol Vis Sci. 1989 Oct;30(10):2174–2178. [PubMed] [Google Scholar]
  10. Wong H. C., Boulton M., Marshall J., Clark P. Growth of retinal capillary endothelia using pericyte conditioned medium. Invest Ophthalmol Vis Sci. 1987 Nov;28(11):1767–1775. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES